The global animal vaccine market size accounted for US$ 14.27 Bn in 2022 and is projected to reach around USD 36.91 Bn by 2032, growing at a CAGR of 9.97% from 2023 to 2032.
Report Summary
The global animal vaccine market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the animal vaccine market across the globe.
A comprehensive estimate on the animal vaccine market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of animal vaccine during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2958
Animal Vaccine Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 15.69 Billion |
Market Size by 2032 | USD 36.91 Billion |
Growth Rate from 2023 to 2032 | CAGR of 9.97% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | By Product Type, By Animal Type, By Route of Administration, and By End User |
Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized animal vaccine market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Smart Sensors Market Size To Cross USD 231.04 Bn By 2032
Animal Vaccine Market Players
The report includes the profiles of key animal vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Merck & Co., Inc.
- Zoetis
- Boehringer Ingelheim International GmbH
- Virbac
- Biogénesis Bagó
- Indian Immunologicals Ltd.
- Elanco
- Ceva
- Phibro Animal Health Corporation
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Ourofino Saúde Animal
Market Segmentation
By Product Type
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Animal Type
- Livestock
- Poultry
- Aqua
- Ruminants
- Swine
- Companion
- Canine
- Feline
By Route of Administration
- Subcutaneous
- Intramuscular
- Intranasal
By End User
- Hospital
- clinics
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Vaccine Market
5.1. COVID-19 Landscape: Animal Vaccine Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Vaccine Market, By Product Type
8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type, 2023-2032
8.1.1. Attenuated Live Vaccines
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Inactivated Vaccines
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Subunit Vaccines
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. DNA Vaccines
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
8.1.5. Recombinant Vaccines
8.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Animal Vaccine Market, By Animal Type
9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type, 2023-2032
9.1.1. Livestock
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Companion
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Animal Vaccine Market, By Route of Administration
10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration, 2023-2032
10.1.1. Subcutaneous
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Intramuscular
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Intranasal
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Animal Vaccine Market, By End User
11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User, 2023-2032
11.1.1. Hospital
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. clinics
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Animal Vaccine Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. Merck & Co., Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Zoetis
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Boehringer Ingelheim International GmbH
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Virbac
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Biogénesis Bagó
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Indian Immunologicals Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Elanco
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ceva
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Phibro Animal Health Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Neogen Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com